In 2016, the highest number of cases of malaria and deaths caused by the disease were in sub-Saharan Africa. In many areas of sub-Saharan Africa, malaria is endemic (continually present) and people are at high risk of becoming infected with the Plasmodium pathogen. In high risk areas it is recommended that: • homes are provided with insecticide-treated nets (ITN) • the surfaces inside homes where Anopheles mosquitoes may rest are sprayed with insecticide. This is known as indoor residual spraying (IRS).
- (a)Explain how the use of ITN and IRS can help break the transmission cycle of malaria.[3]
- (b)(i)Fig. 2.1 shows the proportion of the population in sub-Saharan Africa at risk of malaria that is protected by using IRS or ITN, or both, in the years 2010 to 2016. [Figure 2.1] The main trend in Fig. 2.1 shows that there is an increase in the percentage of the population protected over time. State one other trend shown in Fig. 2.1.[1]
- (b)(ii)Explain why the main trend shown in Fig. 2.1 could be a concern for the World Health Organization.[1]
- (b)(iii)With reference to Fig. 2.1, suggest a reason for the difference in trends shown for ITN only compared with IRS only.[1]
- (c)In a primary immune response, antibodies against Plasmodium are produced within one to two weeks following infection. In some people, the pathogen is eliminated and the concentration of antibodies in the circulation decreases over time. Infection again by Plasmodium with the same antigens causes a secondary response that also involves antibody production. State and explain how the antibody response following a second infection will differ from the primary immune response.[3]
- (d)In malaria, the production of antibodies is beneficial to recovery, whereas in the disease myasthenia gravis the production of antibodies is harmful. Explain why the production of antibodies in a person with myasthenia gravis is harmful.[2]
This question uses a diagram from the original paper, which isn't shown here. Open the full paper from the past papers archive to see it.
Mark scheme
Marking points from the official mark scheme (May/June 2020). The mark or mark type is shown in brackets.
- [3] allow mosquito for Anopheles throughout
- allow pathogen for Plasmodium throughout
- any three from
- role of Anopheles in transmission cycle; e.g. Anopheles is, a vector of Plasmodium / Anopheles passes Plasmodium from infected person to uninfected person
- insecticide on nets and on surfaces
- kills Anopheles before it can take blood from an infected person;
- kills Anopheles before it can transfer blood with Plasmodium to uninfected person;
- presence of nets
- protect people, when sleeping / at time when Anopheles is, active / feeding;
- general
- prevent Plasmodium from completing its life cycle; AW
- AVP; idea of reducing population size of mosquitoes
- use of different insecticides on net and IRS to avoid insecticide resistance
- [1] any one from
- increase in the use of ITN over time;
- decrease in the use of IRS only ;
- proportion of population protected by ITN only has increased ;
- [1] any one from
- increase is not steep enough, to make a large enough difference / so disease will still be able to spread ;
- a large proportion of the population is still at risk, so people will still contract the disease; A figures from Fig. 2.1
- WHO targets may not be met, so hindering progress in the fight against malaria; AW
- AVP; e.g. suggests that the, provision of / distribution of / access to, ITN is not adequate ;
- [1] any one suggestion from
- ITN more effective in control than IRS ;
- more cost effective to provide ITN ;
- lack of personnel to carry out work required for IRS ;
- ref. to insecticide on net may be more effective at killing ;
- AVP; e.g. outside agencies / AW, provide ITN but do not help with IRS
- [3] any three from
- higher concentration of antibodies ;
- faster production of antibodies ;
- because of presence of memory, B-lymphocytes / B cells ;
- higher numbers of specific B-lymphocytes, so increased chance of faster recognition / because of clonal expansion in first response;
- AVP; e.g. also more memory T-cells to stimulate B-lymphocyte response
- ref. to higher concentration antibodies in circulation remaining after recovery
- [2] any two from
- result of an autoimmune disease / AW;
- antibodies produced against, self-antigens / antigens on body cells
- or
- antibodies bind to self-antigens / antigens on (own) body cells;
- detail; e.g. prevents functioning of muscle cells
- binds to receptors on muscle cells
Write your answer and get it marked
On Oracle Prep you can write or photograph your own answer and have it marked by AI against this mark scheme, with feedback on what you missed.
Sign up free →